[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE0201935D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
SE0201935D0
SE0201935D0 SE0201935A SE0201935A SE0201935D0 SE 0201935 D0 SE0201935 D0 SE 0201935D0 SE 0201935 A SE0201935 A SE 0201935A SE 0201935 A SE0201935 A SE 0201935A SE 0201935 D0 SE0201935 D0 SE 0201935D0
Authority
SE
Sweden
Prior art keywords
group
fluoro
optionally substituted
therapeutic agents
prodrugs
Prior art date
Application number
SE0201935A
Other languages
English (en)
Inventor
Lanna Li
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0201935A priority Critical patent/SE0201935D0/sv
Publication of SE0201935D0 publication Critical patent/SE0201935D0/sv
Priority to UA20041210111A priority patent/UA78050C2/uk
Priority to AT03732713T priority patent/ATE386013T1/de
Priority to DE60319084T priority patent/DE60319084T2/de
Priority to EP03732713A priority patent/EP1517883B8/en
Priority to US10/518,007 priority patent/US7355069B2/en
Priority to KR10-2004-7020670A priority patent/KR20050014013A/ko
Priority to DK03732713T priority patent/DK1517883T3/da
Priority to BR0311932-7A priority patent/BR0311932A/pt
Priority to PL03375074A priority patent/PL375074A1/xx
Priority to RU2004137094/04A priority patent/RU2004137094A/ru
Priority to ES03732713T priority patent/ES2299702T3/es
Priority to MXPA04012686A priority patent/MXPA04012686A/es
Priority to AU2003240099A priority patent/AU2003240099B2/en
Priority to CA002489834A priority patent/CA2489834C/en
Priority to TW092116378A priority patent/TWI282784B/zh
Priority to JP2004515007A priority patent/JP3782818B2/ja
Priority to SI200331173T priority patent/SI1517883T1/sl
Priority to PCT/GB2003/002584 priority patent/WO2004000790A1/en
Priority to US10/519,376 priority patent/US7351858B2/en
Priority to PT03732713T priority patent/PT1517883E/pt
Priority to CNB038194740A priority patent/CN1319938C/zh
Priority to ARP030102197A priority patent/AR039713A1/es
Priority to NO20045353A priority patent/NO20045353L/no
Priority to IL16567104A priority patent/IL165671A0/xx
Priority to ZA200410161A priority patent/ZA200410161B/en
Priority to IS7627A priority patent/IS7627A/is
Priority to HK05106401A priority patent/HK1073838A1/xx
Priority to JP2006019068A priority patent/JP2006182782A/ja

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0201935A 2002-06-20 2002-06-20 Therapeutic agents SE0201935D0 (sv)

Priority Applications (29)

Application Number Priority Date Filing Date Title
SE0201935A SE0201935D0 (sv) 2002-06-20 2002-06-20 Therapeutic agents
CNB038194740A CN1319938C (zh) 2002-06-20 2003-06-17 治疗胰岛素抵抗的邻位取代的苯甲酸衍生物
MXPA04012686A MXPA04012686A (es) 2002-06-20 2003-06-17 Derivados de acido benzoico orto-sustituidos para el tratamiento de la resistencia a la insulina.
CA002489834A CA2489834C (en) 2002-06-20 2003-06-17 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
DE60319084T DE60319084T2 (de) 2002-06-20 2003-06-17 Ortho-substituierte benzoesäurederivate zur behandlung von insulinresistenz
EP03732713A EP1517883B8 (en) 2002-06-20 2003-06-17 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
US10/518,007 US7355069B2 (en) 2002-06-20 2003-06-17 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
KR10-2004-7020670A KR20050014013A (ko) 2002-06-20 2003-06-17 인슐린 내성의 치료를 위한 오르토-치환 벤조산 유도체
DK03732713T DK1517883T3 (da) 2002-06-20 2003-06-17 Ortho-substituerede benzoesyrederivater til behandling af insulinresistens
BR0311932-7A BR0311932A (pt) 2002-06-20 2003-06-17 Composto, formulação farmacêutica, método para tratar ou prevenir resistência à insulina, uso de um composto, processo para preparar um composto, e, tratamento combinado
PL03375074A PL375074A1 (en) 2002-06-20 2003-06-17 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
RU2004137094/04A RU2004137094A (ru) 2002-06-20 2003-06-17 Орто-замещенные производные бензойной кислоты для лечения инсулинорезистентности
ES03732713T ES2299702T3 (es) 2002-06-20 2003-06-17 Derivados de acido benzoico orto-sustituidos para el tratamiento de la resistencia a la insulina.
UA20041210111A UA78050C2 (en) 2002-06-20 2003-06-17 Ortho-benzoic acid derivatives for treating insulin resistance
AU2003240099A AU2003240099B2 (en) 2002-06-20 2003-06-17 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
AT03732713T ATE386013T1 (de) 2002-06-20 2003-06-17 Ortho-substituierte benzoesäurederivate zur behandlung von insulinresistenz
TW092116378A TWI282784B (en) 2002-06-20 2003-06-17 Therapeutic agents
JP2004515007A JP3782818B2 (ja) 2002-06-20 2003-06-17 インスリン抵抗性の処置のためのオルト置換安息香酸誘導体
SI200331173T SI1517883T1 (sl) 2002-06-20 2003-06-17 Orto-substituirani derivati benzojske kisline za zdravljenje insulinske rezistence
PCT/GB2003/002584 WO2004000790A1 (en) 2002-06-20 2003-06-17 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
US10/519,376 US7351858B2 (en) 2002-06-20 2003-06-17 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
PT03732713T PT1517883E (pt) 2002-06-20 2003-06-17 Derivados do ácido benzóico substituído na posição orto para o tratamento de resistência à insulina
ARP030102197A AR039713A1 (es) 2002-06-20 2003-06-20 Derivados de acido benzoico orto sustituidos para el tratamiento de resistencia a la insulina
NO20045353A NO20045353L (no) 2002-06-20 2004-12-07 Orto-substituerte benzosyrederivater for behandling av insulinresistens
IL16567104A IL165671A0 (en) 2002-06-20 2004-12-09 Ortho-substituted benzoic acid derivatives for thetreatment of insulin resistance
ZA200410161A ZA200410161B (en) 2002-06-20 2004-12-15 Ortho-substituted benzoic acid derivatives for th e treatment of insulin resistance.
IS7627A IS7627A (is) 2002-06-20 2005-01-05 Orþó-útskiptar bensósýruafleiður til að meðhöndlainsúlínviðnám
HK05106401A HK1073838A1 (en) 2002-06-20 2005-07-26 Ortho-substituted benzoic acid derivatives for thetreatment of insulin resistance
JP2006019068A JP2006182782A (ja) 2002-06-20 2006-01-27 インスリン抵抗性の処置のためのオルト置換安息香酸誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201935A SE0201935D0 (sv) 2002-06-20 2002-06-20 Therapeutic agents

Publications (1)

Publication Number Publication Date
SE0201935D0 true SE0201935D0 (sv) 2002-06-20

Family

ID=20288293

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201935A SE0201935D0 (sv) 2002-06-20 2002-06-20 Therapeutic agents

Country Status (3)

Country Link
SE (1) SE0201935D0 (sv)
UA (1) UA78050C2 (sv)
ZA (1) ZA200410161B (sv)

Also Published As

Publication number Publication date
ZA200410161B (en) 2005-10-20
UA78050C2 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
TW200508180A (en) Therapeutic agents
SE0104334D0 (sv) Therapeutic agents
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
GB0206860D0 (en) Compounds
MX2009004910A (es) Compuestos sustituidos de 3-isobutil-9,10-dimetoxi-1,3,4,6,7,11-b- hexahidro-2h-pirido[2,1-a] isoquinolin-2-ol y métodos que se relacionan al mismo.
BRPI0507984B8 (pt) composto ou um sal do mesmo, processo para produzir um composto, medicamento, métodos para antagonizar angiotensina ii em um mamífero, para melhorar a resistência de insulina em um mamífero e para prevenir ou tratar doenças circulatórias em um mamífero, e, uso do composto
EP1679309A4 (en) ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
MXPA05006798A (es) Ligandos de adenina nucleotido translocasa (ant) y composiciones y metodos relacionados a estos.
TW200503674A (en) Therapeutic agents
RS51146B (sr) Novi difenil-azetidinon sa poboljšanim fiziološkim osobinama postupak za njegovu proizvodnju,lekovi koji sadrže ovo jedinjenje i njihova upotreba
DE60305514D1 (de) Neue verwendung von benzothiazolderivaten
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
SE9904421D0 (sv) New compounds
DE69916066D1 (de) Neue benzoxazole mit pde-hemmender wirkung
SE0104333D0 (sv) Therapeutic agents
CA2489834A1 (en) Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
SE0201936D0 (sv) Therapeutic agents
SE0101978D0 (sv) New compounds
SE0201935D0 (sv) Therapeutic agents
DK0554794T3 (da) Aminobenzoesyrederivater
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
SE0102058D0 (sv) New Salts II
MA27649A1 (fr) Derives d'acylphenyluree substitues par carbonylamino, methode de production et d'utilisation de ceux-ci.
MXPA05013717A (es) Derivados de acido 2-etoxi-2-fenilpropionico para el tratamiento de trastornos de lipido.
ATE395063T1 (de) Pyridlsulfonamidopyrimidine zur behandlung von diabetischer nephropathie